Effectiveness of Ciochorium intibus syrup on non-alcoholic fatty liver

Evaluation of the effect of Ciochorium intibus syrup on clinical and para clinical manifestations of patients with non-alcoholic fatty liver

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181023041431N1

Enrollment

100

Registered

2019-03-09

Start date

2019-03-11

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention 1: Intervention group: Patients are treated with Ciochorium intibus syrup for two months, receiving 8 cc of the syrup three times a day, half an hour before each meal. Metformin is also g

Eligibility

Sex/Gender

All

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Age of over 20 and below 60 Higher than 40 alanine aminotransferase and aspartate aminotransferase serum levels Fatty liver with grade 2 and higher Body mass index of over 27

Exclusion criteria

Exclusion criteria: Pregnancy and breastfeeding Use of alcohol Previous history of confirmed liver diseases Use of any diet or drug for the treatment of fatty liver within the last 3 months Confirmed autoimmune diseases All types of malignancy

Design outcomes

Primary

Measure	Time frame
Serum level of alanine aminotransferase. Timepoint: At the beginning of the study (before the intervention) and at the end of the intervention. Method of measurement: Biochemical tests.;Serum level of aspartate aminotransferase. Timepoint: At the beginning of the study (before the intervention) and at the end of the intervention. Method of measurement: Biochemical tests.;Change in fatty liver grade. Timepoint: Before and after intervention. Method of measurement: Sonography.	—

Measure

Time frame

Serum level of alanine aminotransferase. Timepoint: At the beginning of the study (before the intervention) and at the end of the intervention. Method of measurement: Biochemical tests.;Serum level of aspartate aminotransferase. Timepoint: At the beginning of the study (before the intervention) and at the end of the intervention. Method of measurement: Biochemical tests.;Change in fatty liver grade. Timepoint: Before and after intervention. Method of measurement: Sonography.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Seyed Mousareza Hoseini

Mashhad University of Medical Sciences

hoseinimr@mums.ac.ir+98 51 3801 2742

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026